Connecting: 216.73.216.14
Forwarded: 216.73.216.14, 172.69.6.97:9064
WisdomTree Europe Defence ETF passes $3bn in three months | Trustnet Skip to the content

WisdomTree Europe Defence ETF passes $3bn in three months

01 July 2025

Strong inflows underscore investor momentum amid heightened NATO-driven defence spending.

By Gary Jackson,

Head of editorial, FE fundinfo

The WisdomTree Europe Defence UCITS ETF has gathered $3bn in assets just three months after its launch in March this year.

It was the first ETF to focus solely on European defence and its rapid growth in assets under management reflects strong investor demand for exposure to the region’s military and strategic sectors.

The ETF’s growth coincides with a major shift in European defence policy, as NATO moves from symbolic benchmarks to enforceable spending goals backed by multi-year government commitments.

NATO’s updated guidance calls for 5% of GDP to be directed toward defence, including 3.5% for core capabilities and 1.5% for adjacent sectors such as cybersecurity and infrastructure.

Adrià Beso, head of distribution, Europe at WisdomTree, said: “The NATO summit has made it clearer than ever: European countries are stepping up their defence commitments, with increased spending now a top priority. For investors, this marks the next phase of a long-term shift.

“As governments channel more funds into the defence space, we see strong potential for sustained growth across the sector. Companies that support modern military capabilities and critical infrastructure are well-positioned to benefit, making European defence an increasingly important area for capital allocation.”

Editor's Picks

Loading...

Videos from BNY Mellon Investment Management

Loading...

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.